All posts by imreal

Clovity Expands its IoT Platform Capabilities to Fight Against COVID-19 Using Smart Thermal Cameras


Clovity starts pre-orders for Smart Thermal Camera solution bundle to fight COVID-19

“Clovity is looking forward to implementing this thermal camera solution to help smooth the transition, and help get people back into their schools, hospitals, and places of work.”

As the world begins to open back up, there will be crucial steps that need to be taken to ensure our safety during this current COVID-19 pandemic, as well as future pandemics our planet will face. Silicon Valley-based Clovity, creator of the CSensorNet IoT Platform and professional services provider, has partnered with strategic AI powered camera providers to release zero-touch Thermal Camera bundles powered by Artificial Intelligence and their IoT platform. This bundled solution will be deployed in public and private locations where large amounts of people come into close contact and need to be screened before entering into a facility or gathering space. Pre-configured and “plug & play” ready, this Thermal imaging solution can be rolled out quickly for business to commence normalized daily routines with some peace of mind protection.

Utilizing Clovity’s CSensorNet platform deployed on Microsoft’s Azure cloud, powerful AI cameras will be able to detect in seconds abnormally high temperatures with +/- .5 degrees accuracy walking through a screening corridor or entrance. By identifying surface temperature of potential carriers before they enter an area steps can be taken to alert the person of the issue and remove them from the larger crowd or queue. These individuals will be sent home to quarantine and recuperate while keeping the larger majority safe from infection. This can allow a more “business as usual” type of approach, allowing life to commence with additional levels of health safety for all in attendance.

Vice President, Client Management at Clovity, Joseph Gilman, said, “COVID-19/Coronavirus has obviously affected many people throughout the world in various ways. Clovity is looking forward to implementing this thermal camera solution to help smooth the transition, and help get people back into their schools, hospitals, and places of work.” Joseph continued, “We are glad that we’ve been able to work with our hardware partners to bring value during the ‘new normal’ that we are facing in the coming weeks and months.”

Clovity is currently taking pre-sale orders for Smart Thermal AI Camera solution bundles. If interested, please head to the Clovity Smart Thermal landing page and reach out on the “Contact Us” link!

About Clovity

Clovity is a privately held, Certified Minority-Owned professional services and IoT Platform company based in the heart of Silicon Valley, California. We work to develop smart products, connected solutions and operate as a Service. Clovity is rapidly growing by partnering with many global hardware, software and sensor manufacturers to fully integrate our software into their products and/or software.

Clovity specializes in 4 practice areas – IoT, Cloud, Data and Digital powered by our platform CSensorNet and it brings together “connected things” and data computing closer to the edge, enabling interactions with connected devices to happen much faster. Clovity’s IoT software is geared for the Industrial, Transportation, Retail, Smart Cities, Telecom, Agriculture, Financial Services as well as Healthcare verticals. We have pre-packaged HW/SW bundles for vertical industry focused use cases such as Smart E-Houses, Smart Industrial, Smart Building, Smart Asset etc. which combines our software platform and leading HW providers OOB.

We were named 2018 and 2019 Top Growth IoT Provider in the US by CIO Review magazine as well as 2020 IoT Breakthrough Award for Emerging Company of the Year for the Enterprise Market. Clovity’s platform and global partnerships enable millions of interactions with thousands of connected devices daily, while serving up massive amounts of actionable data in milliseconds for numerous types of vertical use cases.

Clovity is a fully staffed software and services organization, with operations in major US cities and abroad in New Delhi India where our Deliver Center is located. We are also Diversified and Inclusive certified, an approved Government Services Provider, and are a Minority owned Business.

Follow us at:

LinkedIn: https://www.linkedin.com/company/clovity/

Twitter: https://twitter.com/ClovityInc

Share article on social media or email:



Pace Analytical® Receives PFAS Certification from the California Environmental Lab Accreditation Program


PFAS Testing & Analysis

“Pace was one of the first commercial labs to analyze for PFAS compounds – and we work continuously to remain at the forefront as new regulatory and methodologies evolve”

Pace Analytical Services, LLC, the largest American-owned laboratory network providing environmental and life sciences analytical information and services, today announced that it has been certified by the California Environmental Lab Accreditation Program (ELAP) for the testing of PFAS compounds.

ELAP is responsible for accrediting environmental testing laboratories producing analytical data for California regulatory agencies that protect public health. ELAP has certified Pace Analytical to analyze for all PFAS analytes in drinking water using the Environmental Protection Agency (EPA) testing method 537.1. ELAP has also certified Pace for analysis of non-potable water and hazardous waste using the Department of Defense testing method QSM 5.3.

PFAS, or Per- and Polyfluoroalkyl Substances, represent a diverse group of man-made chemical compounds that are persistent; meaning they don’t break down and can accumulate over time. According to the EPA, there is evidence that exposure to PFAS can lead to adverse human health effects. PFAS compounds are resistant to heat, water, and oil and have been used in hundreds of industrial applications and consumer products including carpeting, apparel, upholstery, food paper wrappings, fire-fighting foams, and metal plating. Ongoing concerns over the pervasive use of PFAS have prompted the following recent Federal actions:


  • February 2020: The EPA released an update to its PFAS Action Plan to include preliminary determinations to regulate PFAS contaminants, restrictions to manufacturing and importing of new PFAS chemicals, new drinking water validation methods, and more.
  • March 2020: The Department of Defense (DoD) released an update to its PFAS Task Force Progress Report and announced that it is requiring all public water systems owned and operated by the DoD, be tested for PFAS contamination.

“Pace was one of the first commercial labs to analyze for PFAS compounds – and we work continuously to remain at the forefront as new regulatory and methodologies evolve”, notes Paul Jackson, PFAS Program Manager at Pace Analytical. “ELAP certification is an important milestone for us.” In addition to ELAP, Pace is certified in every state and territory requiring certification for PFAS analysis. The company is also accredited by the Department of Defense (DoD), Department of Energy (DOE), NELAC, and ISO.

Pace Analytical analyzes PFAS compounds through its in-house national network of labs or on-site via PFAST®, the only certified PFAS mobile lab service in the industry. More information on Pace Analytical and its PFAS services may be found at http://www.pacelabs.com.

About Pace Analytical®

Pace Analytical® Services, LLC makes the world a safer, healthier place. For decades, we have been the trusted source for quality environmental and life sciences lab testing and analysis and the resource for scientific lab staffing services. Our work is done in partnership with our clients by providing the science and the data they need to make critical decisions that benefit us all. Pace delivers science better to businesses, industries, consulting firms, government agencies and more through the largest, American-owned and nationally certified laboratory network. More at PACELABS.com

Share article on social media or email:

The National Environmental Education Foundation Partners with CDC to Launch Free Online Certification Course for Pediatric Asthma Management


“We believe that it is imperative for all pediatric healthcare providers to be knowledgeable and comfortable integrating the environmental management of pediatric asthma into their healthcare practice. ” Dr. Lisa de Ybarrondo, Northwest Assistant Ministries Children’s Clinic

The National Environmental Education Foundation (NEEF) is proud to announce the launch of its “Environmental Management of Pediatric Asthma: Guidelines for Healthcare Providers” free online certification course.

Part of NEEF’s Pediatric Asthma Initiative, this accredited eLearning program was developed to help pediatric healthcare providers and clinicians manage environmental asthma triggers and intervention strategies. The online course makes use of case studies, guided exercise, and open dialogue to develop the skills required to identify environmental triggers and implement evidence-based environmental interventions for asthma.

By completing this course, healthcare providers, patients, parents, and caregivers will have the knowledge needed to work together to achieve successful asthma management for children and their caregivers.

“Asthma is considered the most common chronic medical condition in pediatrics. It adversely affects the health and the quality of a child’s life, with increased cost, school days missed, and increased severity of symptoms if not well controlled,” said Dr. Lisa de Ybarrondo, medical director at Northwest Assistant Ministries Children’s Clinic Department of Pediatrics in Houston, Texas, and a NEEF Asthma Faculty Champion. “We believe that it is imperative for all pediatric healthcare providers to be knowledgeable and comfortable integrating the environmental management of pediatric asthma into their healthcare practice.” 

For over 10 years, NEEF has offered free online tools and trained more than 16,000 professionals through its network of “Asthma Faculty Champions”—practicing pediatric physicians with extensive experience who conduct in-person learning sessions. Healthcare providers completing the Environmental Management of Pediatric Asthma: Guidelines for Healthcare Providers online course will receive NEEF’s Asthma Faculty Champion designation.

Professionals completing the course will also be eligible for continuing education units (CEUs) through the Centers for Disease Control and Prevention’s (CDC) Continuing Education certificate program.

“Offering continuing education units will further establish NEEF as an expert in the field of environmental health and increase awareness of the body of evidence that implicates environmental factors in chronic disease progression,” said Vernessa Perry, Health & Wellness program director at NEEF.

The number of education units earned varies depending on each enrollee’s occupation:

  • CME (Physicians) 1.75
  • Certificate of Participation (Non-Physicians) 1.75
  • CEU (Other Professionals) 0.2
  • CECH (Certified Health Education Specialists) 1.5
  • CPH (Certified Public Health Professionals) 2.0

The Environmental Management of Pediatric Asthma: Guidelines for Healthcare Providers eLearning course integrates the CDC’s technical package known as EXHALE, which is comprised of six evidence-based strategies selected for their potential of having the greatest collective impact on controlling asthma. Implementing the knowledge and strategies provided in this course will help to reduce the burden of asthma and help advance CDC’s CCARE (Controlling Childhood Asthma Reducing Emergencies) goal of preventing 500,000 hospitalizations and emergency department visits among children with asthma.

To register for this free online course, visit our website.

 

Share article on social media or email:

Vein911® Vein Treatment Centers Shooting Reality TV Show Pilot


Vein911® Vein Treatment Centers

Vein911® Vein Treatment Centers

“Vein disease is common yet poorly understood by patients and the physician community. We feel a deep responsibility to educate patients and physicians about the effects of vein disease on health and wellness, and have fun while doing it.” — Dr. Chris Pittman, CEO of Vein911® Vein Treatment Centers

Vein911® Vein Treatment Centers announced today the ongoing filming of a reality TV show pilot featuring compelling patient stories and their journeys to renewed health, wellness, and cosmetic appearance. The show highlights the often-hidden aspects of vein disease, which affects over 50% of Americans. The show features state-of-the-art diagnosis and non-surgical treatments including Vein911’s award-winning, world-renowned brand and culture. Patients come from all walks of life as well as athletes, celebrities, politicians, and businesspeople. The pilot is being produced so it can be picked up for syndication through cable or streaming service providers.

Vein disease is poorly understood by patients and the medical community. Most of us recognize varicose veins of the legs, however, 50% of those with significant vein disease never develop bulging varicose veins. Vein disease is recognized as a common cause of lifestyle-limiting problems including leg pain, heaviness, ankle swelling, restless legs, and night cramps. Because vein disease is genetic, it affects even those in excellent health and physical condition.

“I was invited to serve as Chair of the Healthcare Advocacy Committee of the American Vein and Lymphatic Society in 2017. After a year speaking at national and international vein meetings, I felt the best way to advocate for vein disease and to influence physicians and the public was to create a reality TV show”, said Dr. Chris Pittman, Medical Director and CEO of Vein911® Vein Treatment Centers.

“The physician community generally downplays or dismisses vein disease as a cosmetic problem. I feel a deep and passionate responsibility to widely educate patients and my physician colleagues about such a common disease process that is also poorly understood. I’m compelled to share the riveting stories of patients who have spent years seeking answers for their leg problems, but who are often dismissed or do not receive the right answers”, said Dr. Pittman.

About Vein911® Vein Treatment Centers

Vein911® is a leading provider of both medical and cosmetic vein care including varicose veins, ankle swelling, restless legs, night cramps, venous leg ulcers, and cosmetically disturbing veins of the hands, face and legs. Our award-winning, world-renowned vein treatment centers offer state of the art technology within elegant and comfortable surroundings and a family atmosphere. Vein911® is the varicose vein and spider vein treatment center of choice for physicians and their patients who are experiencing vein disease. Our vein treatment centers are conveniently located throughout the Tampa Bay area and are led by world-renowned, board-certified vein care physicians. Our Mission: We’ll Help You Feel Great Again!® Our Vision: Ritz-Carlton service, Disney fun, and FedEx delivery — to be America’s choice for vein care.

Chris Pittman, M.D., FAVLS, FACR

Vein911® Vein Treatment Centers

+1 813-833-1249

Facebook

LinkedIn

YouTube

Instagram

Twitter

Share article on social media or email:



Rigicon launches two new Artificial Urinary Sphincter Systems for Incontinence Treatment


Rigicon announces that ContiClassic® Artificial Urinary Sphincter and the ContiReflex® Artificial Urinary Sphincter models have recently received CE Mark Approval and is initially available in all major European markets.

ContiClassic® Artificial Urinary Sphincter and ContiReflex® Artificial Urinary Sphincter are implant devices that treat Urinary Incontinence (UI). Conti® Artificial Urinary Sphincter Systems are indicated to treat urinary incontinence due to intrinsic sphincter deficiency in cases such as incontinence following prostate surgery. Conti® Artificial Urinary Sphincter Systems are designed to restore the function of the normal (healthy) urinary sphincter that restricts urine flow out of the bladder.

Global roll-out of Conti® Artificial Urinary Sphincter Systems will continue through-out 2020.

A multi-center clinical trial, “Evaluation of the Rigicon Conti® Artificial Urinary Sphincter Systems for the Treatment of Patients with Urinary Incontinence (ERASE UI)”, is scheduled for 2020 Q4.

A.Melih Luleci (VP, Global Operations) added, “Rigicon will continue to expand its offering in prosthetic urology market. We are targeting to launch Conti® Artificial Urinary Sphincter Systems and Infla10® Inflatable Penile Prosthesis in the US market around 2022/Q3.”

About Urinary Incontinence

Urinary incontinence (UI) is the involuntary loss of urine. Patients suffering from Urinary incontinence are unable to control the release of urine from the bladder. While Stress Urinary Incontinence is the most common type, there are different types of urinary incontinence. Stress urinary incontinence is the unexpected leakage of urine when an outside pressure occurs with activities such as heavy lifting, coughing, sneezing, laughing, or exercise. This outside pressure causes the already weakened bladder to leak urine.

Weakened urinary sphincters may be caused by: Surgery in the pelvic area or the prostate, injury to the urethra, medicine, being overweight, changes with age and other causes Urinary incontinence is a significant problem, affecting tens of millions of patients. UI is estimated to affect 1 out of 10 males, with increasing prevalence associated with aging. Men with Urinary Incontinence have a higher rate of depression and are more likely to decrease participation in activities (e.g., decrease work hours, change employment, or take voluntary early retirement)1

The majority of patients who experience weekly urinary incontinence do not seek care for it. Many who sought treatment believe that none was provided and many who received treatment continue to have troubling symptoms.2

About Artificial Urinary Sphincter

Artificial Urinary Sphincter (AUS) is a medical device specifically designed to treat urinary incontinence.

Artificial Urinary Sphincter is a surgical treatment option when non-surgical or behavioral treatment options fail.

AUS will mimic the role of a healthy urinary sphincter (the two muscles controlling the exit of urine from the bladder through the urethra) AUS will close the urethra preventing urine leakage. The patient will squeeze a pump located in his scrotum to release the cuff over the urethra and void. The cuff will return to its closed state in around 2 minutes to prevent urine leakage after voiding. The artificial urinary sphincter is widely regarded as the gold standard for the treatment of Urinary Incontinence.

About Rigicon

Rigicon, Inc. designs and manufactures innovative urological implants with a keen focus on creating a comprehensive product portfolio and a commitment to deliver high quality and innovative urology products for patients and physicians all over the world.

1 Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L., “Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries” BJU International. 2006;97:96–100.

2 Harris S.S., Link C.L., Tennstedt S.L., “Care seeking and treatment for urinary incontinence in a diverse population”, J Urol. 2007;177:680–684

Share article on social media or email:

Prevent Blindness Offers New Educational Resources on Inherited Retinal Diseases, Importance of Genetic Testing and Services


Prevent Blindness declares Inherited Retinal Disease (IRD) Genetic Testing Week, May 17-23, providing new educational resources to the public.

“Inherited retinal diseases can have a significant impact on the quality of life for patients, including affecting the ability to work and live independently,” said Jeff Todd, president and CEO of Prevent Blindness.

In order to help patients with Inherited Retinal Diseases (IRDs) receive an accurate diagnosis through genetic testing, Prevent Blindness, the nation’s oldest volunteer eye health organization, is embarking on a new awareness initiative to educate the public on IRDs, a group of genetic disorders that can cause severe vision loss or total blindness. A recent editorial noted that IRDs are the leading cause of vision loss in persons between 15 and 45 years of age- impacting 1 in every 2,000 people.

To continue the Prevent Blindness mission of preventing blindness and saving sight, the group has declared May 17-23, 2020 as “Inherited Retinal Disease Genetic Testing Week.” As part of this initiative, Prevent Blindness has created a dedicated webpage (to go live on May 15, 2020) with no-cost educational resources on IRDs, providing detailed information on risk factors, therapy and research options, financial assistance services, the importance of genetic testing, and more. Shareable social media graphics on IRDs are also available. Development of these new resources was supported by a donation from Spark Therapeutics, a gene therapy company striving to challenge the inevitability of genetic disease.

The most common types of IRDs include:

  • Retinitis Pigmentosa
  • Choroideremia
  • Stargardt Disease
  • Cone-rod Dystrophy
  • Leber Congenital Amaurosis


All those diagnosed with IRDs should work with their healthcare professional to develop a disease management plan tailored to the patient’s needs.

Patients with suspected IRDs are encouraged to participate in genetic testing, even those who were tested more than five years ago and did not receive a definitive result. According to the National Institutes of Health, genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. The results of a genetic test may provide a detailed diagnosis which confirms or rules out most suspected genetic conditions and the test can help determine a person’s chance of developing or passing on a genetic disorder to their children. Free genetic testing is now available from select organizations and commercial businesses, including through the “ID YOUR IRD” program.

“Inherited retinal diseases can have a significant impact on the quality of life for patients, including affecting the ability to work and live independently,” said Jeff Todd, president and CEO of Prevent Blindness. “Fortunately, today there are more therapies being researched than ever before. We encourage patients and their caregivers to educate themselves on steps that can be taken today to save sight for tomorrow.”

“As a leading gene therapy company with a strong commitment to genetic testing for the IRD community, Spark Therapeutics is pleased to support the Prevent Blindness inaugural IRD Genetic Testing Week,” said Dan Chung, DO, MA, ophthalmology therapeutic area leader, Spark Therapeutics. “We encourage patients living with IRDs and caregivers to pursue genetic testing in order to receive a true, genetic diagnosis.”

For more information on IRDs and genetic testing for vision issues, please call Prevent Blindness at (800) 331-2020 or visit https://www.preventblindness.org/inherited-retinal-diseases. For a listing of vision care financial assistance programs in English or Spanish, visit https://www.preventblindness.org/vision-care-financial-assistance-information.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, or to make a contribution to the sight-saving fund, call 1-800-331-2020. Or, visit us on the Web at preventblindness.org or facebook.com/preventblindness.

Share article on social media or email:

Vidalia Mills Announces New Joint-Venture with Keep It Here to Make Surgical Masks and Gowns


News Image

With the production of these urgently needed masks and garments, we’re working to rapidly build a supply of protective equipment requested by medical professionals and government leaders to help contain the expansion of the Covid-19 virus.

Vidalia Mills, the leading North American maker of yarns and denim fabrics, and Keep it Here, a major Los Angeles-based manufacturing of t-shirts, jeans, and other clothing, have announced a new joint-venture to manufacture and distribute surgical masks, gowns, and face masks to assist medical professionals in limiting the spread of the Covid-19 virus.

Vidalia Mills has purchased one automated surgical grade mask-making machine, along with two automatic N95 high-protection mask-making machines, which will be installed within the next 90 days in a new cleanroom facility under construction at the Vidalia Mills plant and will utilize nonwoven and other advanced textile materials. The machines can produce up to 100 million units annually.

Additionally, Vidalia Mills has deployed twenty high-speed weaving looms to make lightweight cotton fabrics for the production of medical gowns and consumer face masks to be cut and sewn at Keep it Here in Los Angeles. In turn, the materials will be anti-viral and anti-microbial infused, and made with BASF’s e3® sustainable cotton fabrics.

In making the announcement, Vidalia Mills CEO, Dan Feibus, said, “With the production of these urgently needed masks and garments, we’re working to rapidly build a supply of protective equipment requested by medical professionals and government leaders to help contain the expansion of the Covid-19 virus.”

Patrick Stewart, President of Keep it Here, added, “With our highly trained team, we are able rapidly to design and manufacture products. Because of our manufacturing capabilities, we will be able to make a substantial supply of cotton surgical gowns and consumer face masks to help our country in its hour of need.”

Keep it Here (KIH) is a subsidiary of Omniverse Group. This diversified development company has hired Dr. Pietro D. Marghella, an expert in medical and public health emergencies, to oversee the medical requirements of the production at Vidalia and KIH.

Marghella is an accomplished medical professional and former government and military official. He said of the new joint-venture, “I am pleased to work with the teams at KIH and Vidalia to get production ramped quickly by providing sound medical advice to make high-quality products for the medical community and public at large.”

Commenting on Vidalia’s use of BASF’s e3 sustainable cotton for the production of surgical gowns and face masks, Jennifer Crumpler, Director of the e3 sustainable cotton program said, “BASF is pleased to play a role in supplying versatile cotton grown by farmers throughout the United States for much-needed medical equipment. We are proud that our agricultural community is able to assist healthcare workers and citizens with gowns and face masks made from sustainable cotton during this unprecedented time.”

###

Contacts:

Dan Feibus, CEO, Vidalia Mills            

Email: d.feibus@vidaliamills.com        

Patrick Stewart

Email: p.stewart@k2ominiverse.com

http://www.omniverse-group.com

Jennifer Crumpler, Director of e3 Program

Email: Jennifer.gasque-crumpler@basf.com

Share article on social media or email:

Cativa CBD Introduces Two New CBD-infused Drinks


Our teams are continuing to work diligently to bring new products to market that are innovative in delivering the benefits of CBD. We strive to provide products that promote holistic wellness, including relaxation and relief, while elevating the CBD industry as a whole.

Cativa Health (“Cativa CBD”), a science-based cannabidiol (CBD) brand revolutionizing the wellness and CBD industries, announced the launch of its CBD-infused Iced Coffee and a CBD Hibiscus Tea. The drinks, part of the brand’s Balance product line, contain 20 mg of THC-free CBD per can.

“Our mission at Cativa CBD is to bring health and wellness to people through science,” said Luisa Escobar Worrell, the Chief Operating Officer of Cativa CBD. “These two new drinks continue our mission and provide a new means to live healthier and happier lives.”

The Balance CBD Iced Coffee is made with 100% Colombian Arabica beans without preservatives or additives. The coffee is sweetened with cane sugar and infused with broad-spectrum CBD.

It’s sister product, Cativa CBD’s Balance CBD Hibiscus Tea, brings a refreshing taste of hibiscus blossoms mixed with hints of fruit such as apple, papaya, and elderberries. This freshly brewed tea is infused with nitrogen to preserve natural flavors while maintaining the benefits of CBD.

“Our teams are continuing to work diligently to bring new products to market that are innovative in delivering the benefits of CBD,” continued Worrell. “We strive to provide products that promote holistic wellness, including relaxation and relief, while elevating the CBD industry as a whole.”

Alongside these beverages, Cativa offers the following to provide a holistic approach to CBD health:

  • Restore CBD Body Cream, an ultra-moisturizing and restorative CBD body cream that contains up to 200 mg of CBD per bottle.
  • Balance CBD Gum, which delivers CBD’s well-known benefits up to 5 times faster than other forms of CBD oral products and contains 10mg of CBD per tablet.
  • Balance CBD Mints, which supplement existing healthcare regiments and contain 5mg of CBD per mint.

For more information about Cativa CBD and to order products, please visit http://www.cativacbd.com. Samples, photos, and interviews with leadership are available upon request.

ABOUT CATIVA

Cativa CBD is a science-backed CBD brand committed to creating products that work. Founded in 2018, Cativa CBD is dedicated to using the latest in cutting-edge technology and zero-THC CBD isolates. Cativa CBD was founded with a simple mission: to combine the power of science and the promise of nature to deliver wellness and health. We believe in the untapped potential of CBD to heal the mind and body. And, we are committed to building a limitless future where technology and nature work together. We are passionate about science, sustainability, and promoting human health and the environment. And, we are passionate about you. Cativa is sold at retailers and via http://www.CativaCBD.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease.

LEGAL DISCLOSURE

Cativa CBD does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US CSA). The company sells and distributes hemp-based products. Cannabidiol is a natural constituent of hemp.

Media Contacts

Allyson Markey, PR Manager

allyson@theforumpr.com    

858-442-2167

Share article on social media or email:

Miami Schools Respond to Student COVID-19 Trauma with Remote Training for School Staff


News Image

“The Kognito platform and product are a perfect solution for this moment in time.”

Miami-Dade County Public Schools (M-DCPS), the nation’s fourth largest school district, is responding to concerns about student distress during the COVID-19 pandemic by providing all school staff with an innovative online training simulation that enables them to build skills in talking with students experiencing psychological distress. The simulation was developed by Kognito, a leader in health simulations for education and clinical healthcare. According to Kognito, all M-DCPS employees will have access to the simulation starting today, which is also National Children’s Mental Health Awareness Day.

M-DCPS’s Mental Health Services division is leading the initiative out of concern for students, who are experiencing a variety of stressors related to the pandemic. The simulation, Trauma-Informed Practices for K12 Schools, will be available to over 40,000 M-DCPS teachers, administrators, and other school personnel for 12 months. The skills taught will be instrumental in preparing school staff to create a more responsive and welcoming school climate now and through the fall as the district’s 350,000 students start returning to the classroom.

M-DCPS Assistant Superintendent Sally Alayon leads the Mental Health Services division and was instrumental in the decision to adopt the trauma training based on prior success working with Kognito and its programs. She says the enthusiastic reception from staff and the ease of implementation the District experienced using Kognito’s mental health and suicide prevention series last year – part of a statewide initiative sponsored by the Florida Department of Education – made the decision an easy one.

“When schools went remote, we understood immediately that this would be challenging for our students, families and staff,” said Alayon. “The Kognito platform and product are a perfect solution for this moment in time. We went from idea to launch in about two weeks. The simulations are easy to rollout, highly engaging, and backed by evidence. We expect this training to help staff to respond to students, families, colleagues and most importantly themselves with greater empathy and compassion.”

Trauma-Informed Practices for K12 Schools uses interactive role-play scenarios to help educators and staff better support students. Originally created in partnership with UNICEF USA in response to Hurricane Harvey, it prepares users to spot warning signs of trauma, lead real-life conversations with students, improve their experience in class, and explore making a referral to a mental health professional. The simulation was developed with the expertise of internationally known trauma experts, teachers, counselors, nurses, and other school-based mental health professionals.

“Trauma-Informed Practices for K12 Schools will prepare educators to recognize and respond to student behavior that may be the result of trauma or distress.” says Jennifer Spiegler, Senior Vice President of Strategic Partnerships at Kognito. “Miami-Dade County Public Schools is responding to a critical need and taking decisive action that will promote a quicker recovery and a softer landing from this crisis. It is a privilege to witness the rapid decision-making and nimble teamwork of Ms. Alayon and her colleagues in the Mental Health Services division.”

The adoption of trauma-informed training in response to COVID-19 comes on the heels of several M-DCPS district initiatives to address student mental health. In July 2018, the district established the Department of Mental Health Services, whose mission is to promote students’ social-emotional and academic well-being through the highest quality of school and community comprehensive, evidence-based mental health services. Districtwide activities include hiring mental health coordinators, strengthening community resources, mental health curricula for students, and professional development for administrators, educators, and staff.

“As a school district, we provide education, but there are so many factors that contribute to a student’s ability to succeed. The mental health of our students and families is always a priority, especially now,” says Alayon.

About Miami-Dade County Public Schools

Miami-Dade County Public Schools (M-DCPS), an A-rated district, is the nation’s fourth largest school system with nearly 400 schools and a diverse enrollment of more than 350,000 students from over 160 countries. Our ongoing tradition of groundbreaking achievement has earned top recognition at the national and international levels. M-DCPS also recently reached a landmark graduation rate of 89.2 percent. Learn more at dadeschools.net.

About Kognito

Kognito is a health simulation company whose evidence-based simulations harness the power of role-play conversations with virtual humans to improve social, emotional, and physical health. Learn more at kognito.com.

Share article on social media or email:

Family Building through Surrogacy and IVF, Hosted by SGF New York, Circle Surrogacy & Egg Donation, and Fly Bravely


For women and men exploring IVF and surrogacy to grow their family, SGF New York, Circle Surrogacy & Egg Donation, and Fly Bravely will be hosting a free, anonymous virtual panel discussion.

For men and women thinking about their future family, or those ready to start taking steps toward surrogacy and IVF, this virtual informational session will provide answers.

Last month, New York State passed a key piece of legislation, the Child-Parent Security Act, establishing and protecting the rights of surrogates and intended parents pursuing surrogacy journeys in NY state. This change allows those struggling with infertility, cancer survivors, as well as the LGBTQ community to have the opportunity to build their families with the assistance of a gestational carrier (GC) in their home state.

For women and men exploring IVF and surrogacy to grow their family, Shady Grove Fertility (SGF) New York, Circle Surrogacy & Egg Donation, and Fly Bravely will be hosting a free, anonymous virtual panel discussion on May 14, 2020, at 6 PM.

Attendees will hear from three women with three very different stories who grew their families through surrogacy and IVF. Each will share their journeys to motherhood—how the process started, what brought them to surrogacy, and where they are now.

Plus, attendees will hear from experts from SGF New York, Circle Surrogacy & Egg Donation, and Fly Bravely about the IVF and surrogacy process, costs, and more.

Hear from Mothers about their Surrogacy and IVF Experience:


  • Lia Buffa De Feo, Founder of Fly Bravely—a New York City consultancy dedicated to destigmatizing infertility and raising awareness of infant loss by providing information, hope, support and advocacy to New Yorkers who experience difficulty on their family-building journey.
  • Cynara Charles-Pierre who became a mother via surrogacy after eight miscarriages and was a key player in advocacy efforts that resulted in passage of the Child-Parent Security Act.
  • Angela Salerni, a cancer survivor and a mother via surrogacy.

Surrogacy and IVF Expert Panel to Provide Guidance on Process, Cost, Legalities, and More:

  • Anate Brauer, M.D., FACOG: Board-certified reproductive endocrinologist with extensive experience in treating all medical and surgical aspects of infertility. Dr. Brauer serves as SGF’s New York’s IVF Director. SGF is home to the largest donor egg treatment program in the nation.
  • Sam Hyde, President of Circle Surrogacy & Egg Donation.
  • Dean Hutchison, Esq: Vice President of Legal Services at Circle Surrogacy & Egg Donation, and Chairman of the American Bar Association’s Committee on Assisted Reproductive Technology Law.
  • Jen Rachman, LCSW: Licensed Clinical Social Worker and Outreach Associate at Circle Surrogacy & Egg Donation. Jen is also a New York parent through surrogacy.

For men and women thinking about their future family, or those ready to start taking steps toward surrogacy and IVF, this virtual informational session will provide answers.

To register for this complimentary event, click here.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 38 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

About Circle Surrogacy & Egg Donation

Family is our inspiration. With almost 25 years of experience and almost 2,000 babies born, Circle Surrogacy is one of the oldest and most successful full-service surrogate parenting agencies in the world. Our dedicated staff is comprised of social workers, attorneys, program coordinators, accountants, experienced and former surrogates, egg donors and parents through our program. We have achieved unparalleled success rates for our intended parents by controlling costs, managing insurance, securing high-quality IVF treatment, and focusing on our matching process. We offer complimentary consultations as well as informational seminars over Skype, in our office, and in many major cities around the world.

About Fly Bravely

Fly Bravely is a New York City consultancy dedicated to destigmatizing infertility and raising awareness of infant loss by providing information, hope, support and advocacy to New Yorkers who experience difficulty on their family-building journey. As a catalyst for change, we create discourse and establish policies to help people move forward bravely while enduring challenging paths to parenthood.

Share article on social media or email: